1. Home
  2.  |  
  4.  |  
  5. Corporate Current Affairs

Zydus Cadila seeks emergency use nod for ZyCoV-D-world's first plasmid DNA COVID-19 vaccine: Get all details here!

Jul 2, 2021
Zydus Cadila's COVID-19 vaccine, ZyCoV-D is the world's first indigenously made plasmid DNA vaccine against COVID-19. The DNA vaccines produce the same results as mRNA vaccines and so the efficacy of ZyCoV-D is likely to be similar to that of other mRNA COVID vaccines. 

DCGI denies permission to SII for COVOVAX trials on children- All you need to know!

Jul 1, 2021
The Serum Institute of India had applied to the Drugs Controller General of India on June 28, 2021, seeking permission to conduct a trial of COVAVAX on 920 children, 460 each in 12-17 and 2-11 age groups, at sites.

Moderna’s COVID-19 Vaccine: How do mRNA vaccines work against COVID-19? Check out FAQs

Jun 30, 2021
The Moderna COVID‑19 Vaccine uses mRNA to provide a blueprint for cells to build the body’s defense against SARS‑CoV‑2. What are mRNA vaccines? Get all your questions about Moderna's vaccine answered here. 

Covaxin effectively neutralises Delta variant of COVID: NIH

Jun 30, 2021
Covaxin comprises an inactivated SARS-CoV-2 virus that cannot replicate but still stimulates the immune system to make antibodies against the virus. 

Cipla receives DGCI nod to import Moderna’s COVID-19 vaccine for emergency use in India

Jun 30, 2021
Moderna’s COVID-19 vaccine will be the fourth vaccine and the first international vaccine to receive approval for restricted emergency use in India. 

China's CoronaVac vaccine safe and effective in children above 3 years: Study

Jun 29, 2021
The study covers the data from early-stage trials of the vaccine that were conducted on 550 young people. 

NTPC becomes first Indian energy company to declare its Energy Compact Goals at UN dialogue

Jun 28, 2021
National Thermal Power Corporation (NTPC) Limited became the first energy company in India that declared its Energy Compact Goals. Read all you need to know.

Parliamentary panel on Information Technology summons Facebook, Google on June 29

Jun 28, 2021
India’s Permanent Mission at the United Nations, on June 20, 2021, had clarified that the new Information Technology rules introduced by India have been ‘designed to empower the ordinary users of social media'.

Sputnik V: Gurugram’s Fortis Memorial Research Institute starts trial run of vaccine for general public

Jun 28, 2021
The Fortis Memorial Research Institute in Gurugram has started the Trial Run for the general public and has vaccinated 471 people.

COVID-19 Vaccine: Serum Institute manufactures first batch of Covovax, says Adar Poonawalla

Jun 26, 2021
Poonawalla in March 2021 had informed that the clinical trials for COVOVAX vaccine are underway in India and the vaccine will be launched by September 2021. Read all you need to know.

What is indemnity? Why are foreign vaccine makers like Pfizer, Moderna demanding Indemnity from Indian Govt?

Jun 25, 2021
Pfizer and Moderna are seeking indemnity from the countries they are supplying their vaccines so that they can get legal protection. 

44th Reliance AGM 2021: JioPhone Next to be launched on September 10th, Reliance to make India 5G-yukt

Jun 24, 2021
44th Reliance AGM 2021: RIL Chairman announced that JioPhone Next be launched in the market on the occasion of Ganesh Chaturthi on September 10, 2021.  He also said that Jio is not just working to make India 2G-mukt, but also 5G-yukt.

COVID-19 Vaccine: Zydus Cadila to seek emergency authorization for ZyCoV-D vaccine soon

Jun 23, 2021
ZyCoV-D will be the world’s first DNA plasmid-based vaccine against COVID-19 and the fourth vaccine in India in addition to three vaccines. Read all you need to know.

Ban on Flash Sales, Appointment of Compliance Officers - New E-Commerce Rules Explained

Jun 22, 2021
The Government of India announced amendments to the country’s Consumer Protection (E-Commerce) Rules, 2020 to reduce unfair trade practices and protect consumers from getting cheated.

Bharat Biotech submits COVAXIN phase 3 trial data to DGCI; expert panel to meet today to review

Jun 22, 2021
In April 2021, Bharat Biotech said that COVAXIN has shown the efficacy of 78% against mild, moderate, and severe COVID-19 infections, as per the Phase 3 interim analysis results.

Explained: Twitter loses protection under Section 79 of IT Act- What it means?

Jun 16, 2021
Twitter will no longer be protected under Section 79 of the IT Act and its top executives will now be liable for all the content on its platform that is considered inflammatory or considered unlawful in nature.

Bharat Biotech shares complete data of Covaxin research studies 

Jun 15, 2021
The studies conducted on Covaxin's Phase I trials aimed to assess the vaccine's safety, immune response and to determine right dosage.

NOVAVAX COVID-19 vaccine, to be produced by Serum Institute of India, shows 90% efficacy

Jun 15, 2021
NOVAVAX COVID-19 vaccine provides 100% protection against the moderate and severe symptoms of the disease and has shown 90.4 percent efficacy overall in phase 3 trials.

COVAXIN phase 3 trial data to be made public in July 2021

Jun 10, 2021
COVAXIN phase 3 trial data: As per the interim analysis of the Covaxin trials, the vaccine's overall efficacy is 78 percent against symptomatic disease and 100 percent against hospitalizations. 

Register to get FREE updates

  • All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

Get App